RITALIN LA owner Contact Information online
from Novartis AG
RITALIN LA
The mark consists of the words "RITALIN LA" in a stylized format .
US serial number:85010163
Application filling date:Apr. 09, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Feb. 20, 2012
Publication date:Nov. 23, 2010
Abandoned date:Feb. 20, 2012
Standard character claim:No
Mark drawing type:5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM
Goods and services:For: Pharmaceutical preparations for the treatment of central nervous system diseases and disorders
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceutical preparations for the treatment of central nervous system diseases and disorders
Current owner owner name:Novartis AG
Current owner owner address:CH - 4002
Basel
SWITZERLAND
Current owner legal entity type:CORPORATION
Current owner state or country:SWITZERLAND
Attorney name:Maury M. Tepper, III
Attorney email:mtepper@teiplaw.com
Attorney email authorized:Yes
Correspondent name address:MAURY M. TEPPER, III
TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH,
NORTH CAROLINA
UNITED STATES
27609-7321
Correspondent phone:919-861-8903
Correspondent email:mtepper@teiplaw.com
Correspondent fax:919-861-8913
Correspondent email authorized:Yes
Domestic representative name:Novartis Pharmaceuticals Corporation
Domestic representative phone:919-861-8903
Domestic representative fax:919-861-8913
Trademark staff tm attorney:OH, WON TEAK
Trademark staff law office assigned RITALIN LA:LAW OFFICE 114
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (149) JOHNSON & JOHNSON (127) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Nov. 23, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Oct. 05, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Sep. 28, 2010 Apr. 05, 2011
